Eli Lilly & Co., Disney partner to create lifestyle media for families affected by Type 1 diabetes
INDIANAPOLIS — Eli Lilly & Co. and Disney are collaborating to produce a dedicated lifestyle website and publications for families affected by Type 1 diabetes, the two companies said Thursday.
Lilly Diabetes announced the launch of a partnership with Disney Online and Disney Publishing Worldwide to provide inspiration, education and practical advice to families with children who have the disease. Resources include a special hub at Family.com/Type1 and a series of custom books by Disney’s publishing arm for children of various ages and stages of life with diabetes.
More than 13,000 young people are diagnosed every year in the United States with Type 1 diabetes, an autoimmune disorder formerly known as childhood-onset diabetes.
Bayer HealthCare study suggests acne treatment may help sufferers with postinflammatory hyperpigmentation
BERLIN — A new study conducted by Bayer HealthCare suggests that an investigational treatment for acne may be suitable for patients with dark complexions whose acne includes a condition that causes irregular discoloration of the skin known as postinflammatory hyperpigmentation, or PIH.
In the study, published in the Journal of Drugs in Dermatology, patients received azelaic acid in the 15% strength. Patients with dark skin are at increased risk of PIH, which is a widespread side effect of acne vulgaris, and also may result from skin irritation. Bayer and Intendis market the drug around the world under the brand names Skinoren and Finacea.
By the end of the study, in the 16th week, all patients showed at least a “one-grade improvement” in their PIH, while 92% showed a “two-grade improvement” and 31% had complete clearance of PIH.
DOD expands pharmacy’s role in vaccinating TRICARE beneficiaries
ALEXANDRIA, Va. — The U.S. Department of Defense has issued a final rule that, effective Aug. 12, expands the scope of retail pharmacy-provided vaccination services in the TRICARE military healthcare program for the nation’s military, retirees and their families.
Under the DOD’s interim final rule, released on Dec. 10, 2009, retail network pharmacies first were recognized as providers and were authorized to administer the H1N1, seasonal influenza and pneumococcal vaccines to TRICARE patients. For the first six months following publication of that interim final rule, more than 18,000 vaccines were administered in pharmacies. The DOD estimated that more than $1.5 million was saved by administering these vaccines through the pharmacy, rather than the medical, benefit.
The newly released final rule complements the interim final rule and further authorizes retail pharmacies to administer all vaccinations covered under the DOD’s preventive care program, as permitted by state law. And similar to the interim rule, the final rule also waives all co-pays for TRICARE beneficiaries who obtain vaccination services from network pharmacies.
The National Association of Chain Drug Stores on Thursday applauded the issuance of the final rule. “We applaud the Department of Defense for expanding retail pharmacy’s role in administering vaccinations for TRICARE beneficiaries,” stated NACDS president and CEO Steve Anderson. “Pharmacy-provided vaccinations are important preventive healthcare services, which can help prevent the spread of disease, improve patient health and reduce healthcare costs over the long term.”
“As the face of neighborhood health care, pharmacy is committed to improving patient health and reducing costs one patient-pharmacist interaction at a time,” Anderson added. “TRICARE’s recognition of pharmacy’s value further illustrates the critical role of pharmacy in public health and the healthcare delivery system."